<?xml version="1.0" encoding="UTF-8"?>
<item>
    <rel_title>A human monoclonal 1 antibody blocking SARS-CoV-2 infection</rel_title>
    <rel_doi>10.1101/2020.03.11.987958</rel_doi>
    <rel_link>http://biorxiv.org/cgi/content/short/2020.03.11.987958</rel_link>
    <rel_abs>The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19). Vaccines and targeted therapeutics for treatment of this disease are currently lacking. Here we report a human monoclonal antibody that neutralizes SARS-CoV-2 (and SARS-CoV). This cross-neutralizing antibody targets a communal epitope on these viruses and offers potential for prevention and treatment of COVID-19.</rel_abs>
    <rel_authors>Wang, C.; Li, W.; Drabek, D.; Okba, N. M. A.; van Haperen, R.; Osterhaus, A. D. M. E.; van Kuppeveld, F. J. M.; Haagmans, B. L.; Grosveld, F.; Bosch, B.-J.</rel_authors>
    <rel_date>2020-03-12</rel_date>
    <rel_site>biorxiv</rel_site>
</item>